# 

## 



## 

|||Page|
|---|---|---|
|Trustees'<br>report|||
|Statement oftrustees'|responsibilities||
|Independent<br>auditors'|report||
|Statement offinancial|activities|15|
|Balance sheet||16|
|Notes to the accounts||18|





## 

## 

## 

## 

## 



## 

## 

## 

## 



## 



## 

## 



## 

## 

## 

## 



## 



## 

## 

## 

## 



## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

|For the year ended 31|March 2023||||||
|---|---|---|---|---|---|---|
||||||2023||
||||Unrestricted||Total||
||||8||6||
|Income from:|||||||
|Done6ons and legacies|||517,196||617,168||
|Charitable actvttles:|||||||
|Improving<br>Anaesth sale Safety<br>Reducbtg SUrgbal Site lrtfectlons<br>Promottng<br>Surgical Teamwork|||22,178|103,507<br>516,482<br>34,196|103+07<br>616,482<br>66,374|66,070<br>275477<br>8,500|
|Total Income|||539i374|654,184|||
|Expenditure<br>on:<br>Rehdng funds|||31,269|10,534|41,M3|57,197|
|Charitable<br>ectivltko:|||||||
|Improving<br>Anaesthesle<br>Safety<br>Redudng<br>Surgical Site Infections<br>Promoting<br>Surgkol Teamwc&|||138,571<br>111.909|108,317<br>363,533<br>78,024|3$1,617<br>602,104<br>I$9d133|221,146<br>364,848<br>143,123|
|Other Charitable<br>Actlvl6es|||||||
|Total expenditure|||||||
|Net Income I(expenditure)|for the year|13|(16,676)|||160,045|
|Transfers between funds|||||||
|Net Income I(expenditure)|before other||||||
|recognised<br>gains and losses|||(I5,961)||78,201|160,045|
|Olher gains Iposses)|||50,795|||(16,231)|
|Net movement<br>Infunds|||||2<br>7|Ht|
|Reconcglatlon<br>offunds:|||||||
|Total funds brought forward||||1713|||
|Total funds carried forward|||681v813||||





## 


## 



## 

## 

|the year ended 31 INarch|20|23||||||
|---|---|---|---|---|---|---|---|
|CASHFLOW STATEMENT||||||2023|2022|
|AS AT 31 MARCH 2023||||||E||
|Cash flows from Operating<br>Net movement<br>in funds|Activities|||||128,997|143,814|
|AdJustments<br>for:||||||||
|Depreciation||||||||
|Investment<br>income||||||||
|Loss on disposal||||||||
|Exchange (gain)/loss<br>Decrease/(increase)<br>in stock||||||(50,795)<br>14,105|16,231<br>(133,397)|
|Decrease/(increase)<br>In trade <br>Increase/(decrease)<br>in trade <br>Net cash provided by iused|and <br> and <br> Ini|other receivables<br> other payables<br> operating<br>activities||||(142,226)<br>92 459 <br>42 539|(16,957I<br> ~45982<br>5 683|
|Cash flows from Investing<br>activities||||||||
|Dividends,<br>Interest and rent|from investments|||||||
|Proceeds from sale of property,||plant and||equipment||||
|Purchase of property,<br>plant|and|equipment||||||
|Proceeds from sale of investments||||||||
|Purchase of Investments||||||||
|Net cash provided by(used|in)|investing||activities||||
|Financing<br>activities||||||||
|Repayments<br>of borrowing||||||||
|Cash Inflows from net borrowing||||||||
|Receipt of endowment||||||||
|Net cash provided by (used|Ini|financing||activities||||
|Change in cash and cash equivalents<br>period|||In|the|reponin g|42,539|5,683|
|Cash and cash equivalents|at the beginning||||ofthe|||
|reporting<br>period||||||344,555|355,103|
|Change<br>In cash and cash equivalents|||due to||exchange|||
|rate movements||||||||
|||||||59295|—36233|
|Cash and cash equivalents <br>period|atthe end ofthe||||reporting|437,889|344,555|





## 




## 

|Detalhrd comparatlves<br>for|the statement ofnnanclal<br>a|ctlvltles|||
|---|---|---|---|---|
|||2022||2022|
|||Unrestricted|Restricted|Total|
||||2|5|
|Income from:|||||
|Donations<br>and legacies||595,509||59&,609|
|Charkable<br>actlvltles:|||||
|Improving<br>Anaesthesla<br>Safety|||66,070|66,070|
|Reducing Surgical Site Infections<br>Promosng<br>Surgical Teamwork<br>Total Income|||276,278<br>~8|276,278<br>KKQ<br>~7|
|Expenditure<br>on:|||||
|Ralslng Iunds||66,737|4M|57,197|
|Charitable<br>scuvltles:|||||
|Improving<br>Anaesthesla<br>Safety||80,701||221,146|
|Reducing<br>Surgical Site Infections||98,754|266,092|364,846|
|Promoting<br>Surplus) Teamwork||55,408|87,716|143,123|
|Other|||||
|Total expenditure|||||
|Net Income Imrpendlturs|before gainer||||
|gosses) on Investments||303,909|(143,855)|160,045|
|Net gains<br>/ (losses) on Investments||||~1623|
|Net Income Iexpenditure||287,678|(143,865)|143,814|
|Transfers between funds||4587|||
|Net Income l(expenditure)|before other||||
|recognised<br>gains snd losses||433.551|(289,738)|143,814|
|Net movement<br>In funds||433,651|(289,738)|143,814|
|Total funds brought forward|||||
|Total funds carried forward|||||





## 

## 

|Income fro|m donations|and legacies|||||
|---|---|---|---|---|---|---|
||||||2023|2022|
||||Unrestricted|Restricted|Total|Total|
|||||6|6|5|
|Dona5ons|||517,196||617,198|595,500|
|Donated services|||||||
|Income from charitable||actlvltles|||||
||||||2023|2022|
||||Unrestricted|Restricted|Total|Total|
|Improving|Anaesthssla|Safety|||E||
|Donations|&Grants|||103,507|103,607|66,OTO|
|Total||||103,507|103,607|68,070|
||||||2023|2022|
||||Unrestricted|Restricted|Total|Total|
|Reducing <br>Donations|Surgical alta <br>&Grants|Infections||~48||REZZS|
|Total||||516,482|516,482|276,278|
||||||2023|2022|
||||Unrestricted|Restricted|Total|Total|
|Promoting|Surgical Teamwork||||||
|Donations|&Grants||||||
|Total|||22,178||56,374|ILEK<br>8,500|
|Total Income from charitable ecgvltlee|||2 178||||





|||||~e|«mvlhm||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||Cunt rd<br>rahlng|tmsru«m<br> ~|Redudng<br>6urgmel<br>mte|PnamSrrg<br>Other<br>CarSable||Suppen|cavan«m|||
|||funds<br>E|safety<br>6|hdemmne<br>6|Tearmvum<br>6<br>Amtvnm<br>6||uuels<br>E|emml ~<br>6|2023 Tnlal<br>6|2022Toter<br>E|
||||07.340|190,695|135,040||||401,0ST|305,139|
|||41,603|206,330|237,173|23,008||||502222|237,940|
||Staff Sme||||||122,807||122,007|01,121|
||Direst||||||45,109||45,109|42404|
||Slag 0me|||||||||16,026|
||Direst|||||||||13,722|
|||41,003|272,604|435,808|160,054||168,010|37,132|1,116,357|780,312|
||||93,605|53242|21.189||108,016||||
||||la240|12,983|8,090|||37,132|||
|Total olrpondhure||ef,rao|SSI,SIT|502,104|18$,033||||1,110,367|TSESI2|
|Of Ine tarsi expendhure,|66543I40|waa~(202m E295,061) end 2600,400was reetrmtad||||(EIYR|E401261).||||





## 

|Analysis ofstaffcosts, trustee remuneration|and expenses, and the cost ofkey management<br>personnel||
|---|---|---|
|Staffcosts were as follows;|2023|2022|
||8|8'|
|Salaries and wages|469,780|430,205|
|Sodal security costs|66,531|49,391|
|Pension Costs|1<br>11|13|



## 

|Raising funds|Raising funds|
|---|---|
|Charitable|acgvltles|
|Governance||





## 

## 

||||||2023|2022|
|---|---|---|---|---|---|---|
||||||8|8|
||Oxlmeters|&Probes|||167,629|170,722|
||||||187829|181534|
||During the|year purchases|totalled 80.end stack costing 814,105wes dlstrlbuted|to beneactartes|||
|10|Debtors||||||
||||||2023|2022|
|||||||8|
||Trade debtors||||16,636|13,M9|
||Other debtors||||272,998|132,617|
|11|Creditors: amounts falling due wlthlnonsyear||||||
||||||2023<br>f|2022<br>8|
||Taxatlon and sestet security||||26,600|1.782|
||Accruels||||86,161|18.521|
||||||11 781||





## 

## 

|12|Analysis ofnet as|sets|between fund|s||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||Total|
|||||||||||Restricted|||funds|
||||||||||||E||E|
||Net current assets|||||||685,813||95,376|||781,189|
||Netessets at the end ofthe year|||||||6858 3|||38||711 9|
||||2022|||||||||||
||Net current assets|||||||650,979||1,213|||652,192|
||Net assets atthe end ofthe year|||||||||1|21|||
|13|Movements<br>Infunda||||||Incoming|Outgoing||Transfers|5|||
|||||At|the start||resources 8|resources 5||Other|||At the end|
|||||ofthe year|||gains|losses|Gains/Losses||||ofthe year|
||||||E||E|E|||E||E|
||||2023|||||||||||
||Restrhted funds:|||||||||||||
||Fundralslng||||||10,994|10,534||||||
||Improving<br>Anaesthesla||Safety||83,943||192,260|108,317|||||0|
||Redudng<br>Surgical <br>Promoting<br>Surghal|Ste Infecdons<br> Teams||172,509<br>86,893|||286,014<br>164,917|363,633<br>78,024|||386||95,378<br>0|
||Other Charitable<br>Acdvttles|||||||||||||
||Total restricted funds|||||~sac||~oar|||366|||
||General funds|||623,230|||539,374|554,949||f366)|||607,269|
||Currency Reserve||||27,749||50,795|||||||
||Total unrestricted|funds|||||169|55<br>49|||6||68<br>1|
||Totalfunds|||~K3II2|||63|1 11<br>7||||||
||||zu|||||||||||
||Restricted funds:|||||||||||||
||Fundraislng|||||||||||||
||Improving<br>Anaesthesla||Safety||15,122||66,070|140,445|-|24,690||-|83,943|
||Redudng<br>Surghel|Site|Infeudate||104,332||276,278|266,092||57,992|||172,610|
||Promoting<br>Surghal|Teamwork|||171,497||8,500|87,716|-|179,175||-|86,894|
||Other Charitable<br>Acuvitles|||||||||||||
||Total restricted funds|||~slllrr||||||||||
||General funds||||175,128||595,509|291,599||145,873|||624,911|
||Currency Reserve||||42,299|-|I6431||||||28,068|
||Total unrestricted|funds||217427|||579278|291 699||1|873||86|
||Total funds||||||930128|7883 2|||||II~12|
||Purposes ofrestricted||funds|||||||||||





## 

## 

## 

## 

## 


